MU researchers receive funding for innovative cancer research
Cancer treatment inserted into individual cancer cells, instead of a more scattershot approach of chemotherapy that also harms healthy cells, is an approach University of Missouri researchers are pursuing — now with more funding.
Developing a targeted delivery system to treat cancer: Grant helps propel a collaborative research team at the University of Missouri to drive toward achieving success in fighting cancer
In the ongoing battle to find ways to treat cancer, a team at the University of Missouri is addressing the problem from multiple angles, but with a precision approach.
Midwest Biomedical Accelerator Consortium award helps Principal Investigator George Gokel combat antibiotic resistance
At the beginning of the year, Distinguished Professor of Chemistry and Biochemistry George Gokel found himself back in class – but not in his regular role as a faculty member at the University of Missouri–St. Louis. This time, Gokel was the student.
MU receives nearly $4 million from National Institutes of Health to commercialize biomedical discoveries
The National Institutes of Health has awarded the University of Missouri-Columbia nearly $4 million to direct a consortium of midwestern universities that will collaborate to turn biomedical discoveries into marketable products.
NIH to fund hubs to accelerate development of biomedical health technologies
The National Institutes of Health has awarded $20 million to fund five additional hubs designed to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care and enhance health.